HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

navitoclax

a BH3 mimetic antineoplastic
Also Known As:
ABT 263; ABT-263; ABT263
Networked: 365 relevant articles (62 outcomes, 81 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Leverson, Joel D: 16 articles (01/2022 - 12/2011)
2. Karpel-Massler, Georg: 11 articles (08/2021 - 06/2015)
3. Shu, Chang: 11 articles (08/2020 - 07/2014)
4. Siegelin, Markus D: 11 articles (08/2020 - 07/2014)
5. Elmore, Steven W: 10 articles (08/2015 - 05/2008)
6. Rosenberg, Saul H: 10 articles (03/2015 - 05/2008)
7. Souers, Andrew J: 9 articles (01/2022 - 02/2013)
8. Westhoff, Mike-Andrew: 9 articles (08/2021 - 06/2015)
9. Sampath, Deepak: 8 articles (01/2019 - 03/2011)
10. Tahir, Stephen K: 8 articles (01/2017 - 05/2008)

Related Diseases

1. Neoplasms (Cancer)
2. Fibrosis (Cirrhosis)
3. Thrombocytopenia (Thrombopenia)
4. Inflammation (Inflammations)
5. Small Cell Lung Carcinoma (Small Cell Lung Cancer)

Related Drugs and Biologics

1. navitoclax
2. venetoclax
3. ruxolitinib
4. S63845
5. Docetaxel (Taxotere)
6. Antineoplastic Agents (Antineoplastics)
7. Biomarkers (Surrogate Marker)
8. Proteins (Proteins, Gene)
9. Paclitaxel (Taxol)
10. Rituximab (Mabthera)

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Withholding Treatment
4. Chinese Traditional Medicine (Traditional Chinese Medicine)
5. Radiotherapy